88 related articles for article (PubMed ID: 8353592)
1. In vitro transformation of epithelial cells by ras oncogenes.
Burns J; Barton C; Wynford-Thomas D; Lemoine N
Epithelial Cell Biol; 1993 Jan; 2(1):26-43. PubMed ID: 8353592
[TBL] [Abstract][Full Text] [Related]
2. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.
Lemoine NR; Staddon S; Bond J; Wyllie FS; Shaw JJ; Wynford-Thomas D
Oncogene; 1990 Dec; 5(12):1833-7. PubMed ID: 1704496
[TBL] [Abstract][Full Text] [Related]
3. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways.
Bounacer A; McGregor A; Skinner J; Bond J; Poghosyan Z; Wynford-Thomas D
Oncogene; 2004 Oct; 23(47):7839-45. PubMed ID: 15361839
[TBL] [Abstract][Full Text] [Related]
4. Creation of human tumour cells with defined genetic elements.
Hahn WC; Counter CM; Lundberg AS; Beijersbergen RL; Brooks MW; Weinberg RA
Nature; 1999 Jul; 400(6743):464-8. PubMed ID: 10440377
[TBL] [Abstract][Full Text] [Related]
5. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Ras transformation of human thyroid epithelial cells.
Poghosyan Z; Wynford-Thomas D
Methods Enzymol; 2006; 407():648-60. PubMed ID: 16757359
[TBL] [Abstract][Full Text] [Related]
7. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
8. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
9. R-Ras promotes tumor growth of cervical epithelial cells.
Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
[TBL] [Abstract][Full Text] [Related]
10. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
[TBL] [Abstract][Full Text] [Related]
11. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
12. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
13. Transforming collaborations between ras and nuclear oncogenes.
Ruley HE
Cancer Cells; 1990; 2(8-9):258-68. PubMed ID: 2223387
[TBL] [Abstract][Full Text] [Related]
14. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
15. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Ras dominates overexpression of E-cadherin in malignant transformation of intestinal epithelial cells.
Schmidt CR; Gi YJ; Coffey RJ; Beauchamp RD; Pearson AS
Surgery; 2004 Aug; 136(2):303-9. PubMed ID: 15300195
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic transformation of human cells: shortcomings of rodent model systems.
Akagi T
Trends Mol Med; 2004 Nov; 10(11):542-8. PubMed ID: 15519280
[TBL] [Abstract][Full Text] [Related]
18. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
19. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
20. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
